David Kentner

David leads CHO cell line development projects at Novartis. With more than ten years of experience in the field, he has extensive expertise in the expression and development of a wide range of biologic modalities, from early research through clinical manufacturing. David earned his PhD in Biology from the University of Heidelberg.